Universe Pharmaceuticals ... (UPC)

NASDAQ: UPC · Real-Time Price · USD

4.80

-0.08 (-1.64%)

At close: May 02, 2025, 2:25 PM

Universe Pharmaceuticals INC Cash Flow Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018
Net Income	-6.16M	-8.74M	11.32M	7.56M	7.55M	7.6M
Depreciation & Amortization	508.79K	533.95K	446.88K	410.08K	418.43K	452.73K
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	1.45M	10.02M	-10.82M	713.52K	-166.52K	-654.88K
Other Non-Cash Items	-526.91K	906.59K	-468.17K	22.71K	112.79K	-85.19K
Deferred Income Tax	679.59K	-605.28K	-668.34K	-9.89K	-39.63K	17.54K
Change in Working Capital	6.62M	6.59M	-12.69M	-1.87M	5.16M	-3.53M
Operating Cash Flow	1.12M	-1.31M	-2.06M	6.12M	13.2M	4.46M
Capital Expenditures	-44.17K	-93.7K	-13.53M	-51.8K	-86.32K	-145.09K
Cash Acquisitions	n/a	-3.81M	26.62M	n/a	291.00	n/a
Purchase of Investments	n/a	n/a	-15.33M	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	1.8M	n/a	n/a	n/a
Other Investing Acitivies	n/a	523.00	-26.62M	n/a	-0.00	n/a
Investing Cash Flow	-44.17K	-3.91M	-27.06M	-51.8K	-86.03K	-145.09K
Debt Repayment	1.7M	n/a	624.35K	911.2K	1.14K	-1.85M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	-16M	-3.06M
Other Financial Acitivies	-3.09M	3.32M	-2.79M	-441.06K	n/a	n/a
Financial Cash Flow	-1.39M	3.32M	26.58M	470.14K	-16M	-4.91M
Net Cash Flow	-426.21K	-2.37M	-1.98M	6.88M	-3.01M	-793.24K
Free Cash Flow	1.08M	-1.41M	-15.59M	6.06M	13.12M	4.31M